Dietary and Lifestyle Advice and Treatment for Women with Borderline Gestational Diabetes: The IDEAL Randomised Controlled Trial

澳大利亚每年有超过22，000名孕妇（占怀孕人数的7.7%）患上临界妊娠期糖尿病（GDM）。IDEAL试验正在评估实施饮食和生活方式建议并监测边缘GDM女性的血糖是否能有效降低妇女和婴儿严重健康后果的风险。如果对这些妇女的治疗是有效的，这将减少妇女及其婴儿的疾病负担，并对改善儿童、青少年和成年期的健康产生影响。

Over 22,000 pregnant women in Australia each year (7.7% of pregnancies) develop Borderline Gestational Diabetes Mellitus (GDM). The IDEAL Trial is assessing whether implementing dietary and lifestyle advice and monitoring blood glucose in women with Borderline GDM is effective in reducing the risk of serious health outcomes for women and infants. If treatment of these women is effective this would reduce the burden of disease for women and their babies, with implications for improved health through childhood, adolescence and adulthood.